🕵️ Drugs MADE In America Acquisition II Corp. ($DMIIR)
SEC insider & ownership activity, last 12 months · CIK 2040475 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
2 buyers, $0 (4 lots) · 2 sellers, $0 (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Drugs MADE In America Acquisition II LLC | 2 | – | 1 | – | Sep 26, 2025 |
| Lynn Stockwell | 2 | – | 1 | – | Sep 26, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Drugs MADE In America Acquisition II LLC | 10.2% | 13D | Oct 1, 2025 | filing ↗ | |
| Lynn Stockwell | 10.2% | 13D | Oct 1, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Apr 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 22, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 24, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 24, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 11, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 11, 2026 | filing ↗ |
| Other events (8.01) | Mar 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 11, 2026 | filing ↗ |
| Other events (8.01) | Mar 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 28, 2026 | filing ↗ |
| Officer/director changes (5.02) | Oct 8, 2025 | filing ↗ |
| Other events (8.01) | Sep 26, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 26, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 24, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 24, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 24, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Sep 24, 2025 | filing ↗ |
| Other events (8.01) | Sep 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 24, 2025 | filing ↗ |